Emma Cauzzi
Rome, 00128, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Midbrain dopamine loss drives parvalbumin interneuron vulnerability through tissue plasminogen activator-linked perineuronal-net breakdown and hippocampal disinhibition.
Journal: Neurobiology of disease
Published: May 11, 2026
Microglial clearance, neuroprotection and cognitive recovery via a novel synthetic sulfolipid in Alzheimer's disease.
Journal: Journal of neuroinflammation
Published: August 18, 2025
Optogenetic stimulation of midbrain dopaminergic neurons rescues hippocampal synaptic plasticity deficits in a mouse model of Alzheimer's disease.
Journal: Translational psychiatry
Published: March 25, 2025
Repetitive prefrontal tDCS activates VTA dopaminergic neurons, resulting in attenuation of Alzheimer's Disease-like deficits in Tg2576 mice.
Journal: Alzheimer's research & therapy
Published: February 17, 2025
Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer's Disease.
Journal: Molecular neurodegeneration
Published: January 13, 2025
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer's Disease.
Journal: Molecular psychiatry
Published: July 28, 2023
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice.
Journal: Molecular neurodegeneration
Published: September 21, 2022
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease.
Journal: Progress in neurobiology
Published: June 24, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026